Analysis of samples from completed PsiOxus sponsored clinical trials

  • Research type

    Research Study

  • Full title

    Analysis of patient samples from completed PsiOxus clinical trials to aid in understanding of drug mechanism of action and to develop assays for future use

  • IRAS ID

    287283

  • Contact name

    David Krige

  • Contact email

    david.krige@psioxus.com

  • Sponsor organisation

    PsiOxus Therapeutics Ltd

  • Duration of Study in the UK

    5 years, 0 months, 1 days

  • Research summary

    The study will analyse samples obtained from clinical trials in oncology to develop knowledge of the mechanism of action of the investigational product and also to improve methods for the analysis of samples. The research will include blood and urine samples and tumour tissue from PsiOxus sponsored clinical trials. There is no direct benefit to the patients that participated in the trials but this study may help understand the mechanism of action of the investigational product and will support future studies to ensure that samples obtained are used efficiently and effectively.

  • REC name

    South Central - Oxford C Research Ethics Committee

  • REC reference

    20/SC/0454

  • Date of REC Opinion

    21 Dec 2020

  • REC opinion

    Favourable Opinion